Difference between revisions of "Team:Technion Israel/Project/Overview"

Line 10: Line 10:
 
background-color: rgb(255, 184, 106);
 
background-color: rgb(255, 184, 106);
 
}
 
}
header{background-image: url("https://static.igem.org/mediawiki/2015/f/fc/Technion_Israel_2015_heading_Project_overview.jpg"); background-size: 100%; background-repeat: no-repeat; width: 100%; height: 300px;}
+
 
header h1{ color: rgb(255, 184, 106); font-size: 70px;}
+
header{background-image: url("https://static.igem.org/mediawiki/2015/f/fc/Technion_Israel_2015_heading_Project_overview.jpg"); background-size: 100%; background-repeat: no-repeat; width: 100%; height: 450px; margin-bottom: 0px;}
 +
.title h1{ color: rgb(255, 184, 106); font-weight: bold; font-size: 100px; text-align: center; background: rgba(0, 0, 0, 0.8); font-family: sans-serif; font-style: Arial; height: 100px; text-shadow: black 6px 6px 6px; line-height: 80px;}
 +
#bodyContent h1{margin-bottom: 0em;}
 +
 
 +
.content{padding: 20px;margin-top: 0px;}
 
 
#label{font-style: bold; font-family: sans-serif; font-style: Arial; text-shadow:4px 4px orange; height: 300px; line-height: 80px; width: 100%; text-align: center; vertical-align: center;}
 
 
</style>
 
</style>
 
<title>Team: Technion 2015</title>
 
<title>Team: Technion 2015</title>
Line 75: Line 78:
  
  
 
<div class="content">
 
 
<header>
 
<header>
<div id="label">
+
</header>
<br><h1>Project Overview</h1>
+
<div class="title">
 +
<h1><b>Project Overview</b></h1>
 
</div>
 
</div>
</header>
+
<div class="content">
 
<h1 class="abstract_title">Hello! Welcome to our temporary wiki page!</h1>
 
<h1 class="abstract_title">Hello! Welcome to our temporary wiki page!</h1>
 
<div class="abstract">
 
<div class="abstract">

Revision as of 11:55, 17 September 2015

Team: Technion 2015

Project Overview

Hello! Welcome to our temporary wiki page!

Our team is developing a treatment for male pattern baldness.

Hair loss affects roughly 61 million people in the United States. More than 95% of hair thinning in men is attributed to male pattern baldness, or androgenetic alopecia. The hair loss product market is a multi-billion dollar market: in the United States alone, this market’s annual revenue is 7 billion dollars, with 3.5% annual growth rate from 2007 to 2012, yet a sufficient solution has yet to be made available. The trigger for androgenetic alopecia is believed to be dihydrotestosterone (DHT), a derivative of testosterone. This summer, we are engineering Bacillus Subtilis, a model organism for a bacterium found naturally on the scalp, to secrete 3?-hydroxysteroid dehydrogenase (3-?-HSD). This enzyme reduces DHT to a non-steroidically active compound, using NADPH and NADH as cofactors.

Our project consists of 3 main parts: 3-?-HSD secretion by the bacterium, engineered bacterium for NADPH overproduction, and a comb as a tool to create a user-friendly experience. By synchronizing these parts, we hope to be able to show convincing evidence of DHT breakdown, providing a promising platform for treatment of male pattern baldness!

Contact Us